This JAMA Forum discusses long-awaited reforms that could modernize the US Food and Drug Administration’s regulatory processes, promote innovation, and provide US consumers greater assurance that the products they use are safe and reliable.
No takes yet. Share an insight, caveat, or question.
Gottlieb et al. (2022) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: